-
Diagnostics World News | A prominent urologic oncologist has helped develop a urine test found to be strikingly predictive of bladder cancer recurrence among patients undergoing surgery followed by BCG therapy, the current gold standard treatment regimen. The liquid biopsy also tends to identify recurrence risk that is missed by routine cystoscopy exams.
Jun 4, 2026
-
Diagnostics World News | At last month's Bio-IT World Conference & Expo, the opening plenary session featured an intimate series of paired conversations, each designed to place a different set of puzzle pieces on the table, examining that puzzle from four distinct vantage points — patient experience, AI-assisted diagnostics, venture investment, and policy reform — with each conversation delivering a bit more clarity to the emerging picture.
Jun 2, 2026
-
Diagnostics World News | Myriad Genetics launches the Prolaris + AI Test for prostate cancer; Lucent Diagnostics announce a collaboration with Tempus AI; Oxford Nanopore Technologies and Lonza launch new technology to modernize and accelerate GMP quality control testing for mRNA therapeutics; and more.
May 29, 2026
-
Diagnostics World News | At Scope X, Novo Nordisk gave a presentation on how high-impact opportunities for leveraging AI across the pharmaceutical R&D cycle are too numerous to count but won’t “automagically” solve any of the longstanding problems in ushering molecules to market. AI requires human attention to match tools to tasks for ensuring the accuracy of model predictions, and the pitfalls are dangerously easy to miss,
May 27, 2026
-
Diagnostics World News | Isomorphic Labs plans to continue development and deployment of its AI drug design engine; NVision expands POLARIS platform into quantum computation; Kanvas Biosciences advances commercial partnerships that leverage the company’s spatial imaging and manufacturing platform; and more.
May 26, 2026